Pfizer expects the market for new obesity pills to be $90 billion per year. Lilly, Novo, and many biotechs hope to claim chunks of it.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Pfizer’s Obesity Pill Disappointed. Biotech Rivals Are Rubbing Their Hands.